Yuyu Pharma (000220) — Cash Flow-to-Debt Ratio
Yuyu Pharma (000220) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩836.62 Million could theoretically repay 0% of its total liabilities (₩63.32 Billion) in one year. Explore Yuyu Pharma long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yuyu Pharma Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Yuyu Pharma across 14 annual periods. Also explore total assets of Yuyu Pharma for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Yuyu Pharma (2011–2024)
Year-by-year debt coverage analysis for Yuyu Pharma. For market capitalisation and broader financial context, see Yuyu Pharma (000220) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | ▲ +241.1% |
| 2013 | -0.03x | ₩-775.17 Million | ₩23.99 Billion | ▼ -109.5% |
| 2012 | 0.34x | ₩6.51 Billion | ₩19.18 Billion | ▲ +8.2% |
| 2011 | 0.31x | ₩6.67 Billion | ₩21.28 Billion | — |